Significant Ownership of MAVERICK CAPITAL LTD

Notable people
Lee Ainslie
Signature - Title
/s/ Trevor Wiessmann* - By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by MAVERICK CAPITAL LTD.

Notify me when MAVERICK CAPITAL LTD files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of MAVERICK CAPITAL LTD

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IVVD Invivyd, Inc. Common Stock, $0.0001 par value per share 8.5% $8,899,333 10,229,118 Maverick Capital, Ltd. 30 Jun 2025
RCKT Rocket Pharmaceuticals, Inc. Common Stock, $0.01 par value per share 7.8% $28,018,774 +$9,435,737 8,363,813 +51% Maverick Capital, Ltd. 30 Jun 2025
BTU Peabody Energy Corporation Common Stock, par value $0.01 per share 6.7% $216,334,593 +$40,034,141 8,157,413 +23% Maverick Capital, Ltd. 30 Sep 2025
WVE Wave Life Sciences Ltd. $0 Par Value Ordinary Shares 5.4% $50,724,026 8,261,242 Maverick Capital, Ltd. 31 Dec 2024
VRNA Verona Pharma Plc Ordinary Shares, nominal value 0.05 GBP per share 3.8% $1,449,378,892 25,028,128 Maverick Capital, Ltd. 31 Dec 2024
GUTS Fractyl Health, Inc. Common Stock, $0.00001 par value per share 3.1% $6,755,102 4,248,492 Maverick Capital, Ltd. 30 Sep 2025
CRIS Curis, Inc. Common Stock, par value $0.01 per share 0.4% $84,490 -$1,077,265 49,554 -93% Maverick Capital, Ltd. 30 Sep 2025

Schedules 13D/G Reported by MAVERICK CAPITAL LTD:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.